Newsletters

MAPS January Email News Update Dear MAPS Members, Supporters, & Friends, Happy new year! We have a lot of exciting work in store for you in 2008 — although were starting the year with some sad …

Dear MAPS Members, Supporters, & Friends, Hello from David Jay Brown. Im going to be a guest editor at MAPS starting with this monthly email update, now that Jag Davies is on a well-deserved vacation …

MAPS Members, Supporters & Friends, There’s a flurry of activity on the horizon to close out the year, and an incredible slate of studies that are set to begin in early 2008. MAPS has four government-approved …

MAPS Members, Supporters & Friends, As MAPS’ psychedelic research agenda continues to move forward slowly but surely, it’s gratifying to announce that psychedelic research pioneer Stanislav …

MAPS Members, Supporters & Friends, I am pleased to announce that tomorrow, September 19, a letter will be delivered to DEA Administrator Karen Tandy signed by 45 members of the U.S. House of Representatives. …

MAPS Members, Supporters & Friends, This August, things are — excuse the corny summer pun — heating up here at MAPS. Rep. John Olver (D-MA) has extended the deadline one final time to September …

MAPS Members, Supporters & Friends, The last time MAPS’ research agenda was debated in a Congressional hearing was 1996, when — to our surprise — C-SPAN broadcast a Senate hearing …

MAPS Members, Supporters & Friends, Incredibly, over the last several years, MAPS’ research agenda has transformed the distant dream of developing psychedelics into government-approved prescription …

MAPS Members, Supporters & Friends, The fate of MAPS’ quest to put marijuana through FDA clinical trials is in a thrilling but precarious position — the DEA’s hands. After six years …

MAPS Members, Supporters & Friends, With all the good news about the resurgence of psychedelic research and changing public attitudes about psychedelics and medical marijuana, it is sometimes easy …

MAPS Members, Supporters & Friends, As momentum builds for psychedelic and marijuana research and reform, we’re working more than ever to educate the media and the public about these important …

MAPS Members, Supporters, and Friends, MAPS has been attempting for years to put marijuana through FDA-approved clinical trials to resolve the controversy over medical marijuana’s safety and efficacy, …